You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Hydrochlorothiazide; losartan potassium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for hydrochlorothiazide; losartan potassium and what is the scope of patent protection?

Hydrochlorothiazide; losartan potassium is the generic ingredient in two branded drugs marketed by Organon, Alembic Pharms Ltd, Apotex, Aurobindo Pharma, Granules, Hikma, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, Sandoz, Teva Pharms, Torrent Pharms, Unichem, Watson Labs, and Zydus Pharms Usa Inc, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

Thirty-one suppliers are listed for this compound.

Summary for hydrochlorothiazide; losartan potassium
Recent Clinical Trials for hydrochlorothiazide; losartan potassium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Kyushu UniversityPhase 3
Federico II UniversityPhase 4

See all hydrochlorothiazide; losartan potassium clinical trials

Pharmacology for hydrochlorothiazide; losartan potassium
Paragraph IV (Patent) Challenges for HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
HYZAAR Tablets hydrochlorothiazide; losartan potassium 100 mg/12.5 mg 020387 1 2006-04-04
HYZAAR Tablets hydrochlorothiazide; losartan potassium 50 mg/12.5 mg and 100 mg/25 mg 020387 1 2004-05-24

US Patents and Regulatory Information for hydrochlorothiazide; losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 077948-001 Oct 6, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Unichem LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 204832-003 Jul 21, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jubilant Cadista LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 201845-003 Sep 18, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 077157-002 Apr 6, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Granules LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 218015-001 Sep 29, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Granules LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 218015-002 Sep 29, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 090150-001 Oct 6, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for hydrochlorothiazide; losartan potassium

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.